Serratus Plane Block for Rib Fractures

NCT ID: NCT03664973

Last Updated: 2025-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-03

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with ipsilateral multiple rib fractures will be randomized to receive either a single-shot ultrasound-guided serratus plane block, or a continuous serratus plane block within 24h from the chest trauma. Primary outcome is the difference in forced respiratory volume (FEV1) at 72h.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients admitted in emergency department with a chest trauma and ipsilateral multiple rib fractures, will be randomized as described above. All patients will receive the serratus block with a ropivacaine 0.37% solution 20 ml. Then, they will randomized to receive either a peripheral catheter placed above the 5th rib on the middle axillary line, or nothing. In all patients postoperative analgesia also include Paracetamol 1g IV each 6h and a patient controlled analgesia (PCA) of morphine set out as follow: bolus 1 mg, loch out 15 min, max 4 boluses each hour. In all patients an arterial blood sample for gas analysis and a FEV1 will be achieved before the block, after 1 hour and at 72h.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chest Trauma Chest Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

continuous

continuous local anesthetic infusion (ropivacaine 0.2%)on the serratus plane for at least 72h adds to a Single-shot serratus plane block with ropivacaine 0.37% solution 20 ml.

Group Type EXPERIMENTAL

Serratus plane block

Intervention Type PROCEDURE

Local anesthetic infusion though a peripheral nerve catheter placed on the 5th rib under the serratus plane

single-shot

Single-shot serratus plane block with ropivacaine 0.37% solution 20 ml

Group Type ACTIVE_COMPARATOR

Serratus plane block

Intervention Type PROCEDURE

Local anesthetic infusion though a peripheral nerve catheter placed on the 5th rib under the serratus plane

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Serratus plane block

Local anesthetic infusion though a peripheral nerve catheter placed on the 5th rib under the serratus plane

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 2 o more ipsilateral rib fractures
* Trauma within 24h from hospital admission
* Informed consent

Exclusion Criteria

* Chest drain
* head trauma
* bilateral rib fractures
* Intensive care admission
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AUSL IRCCS Reggio Emilia

Reggio Emilia, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Serratus GC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Paravertebral Block in Thoracic Outlet Syndrome
NCT05544721 ENROLLING_BY_INVITATION PHASE4
Flail Chest - Rib Fixation Study
NCT01147471 TERMINATED NA